TARGETING ENDOTHELIAL CELL AND CANCER AMOEBOID MOVEMENT TO OVERCOME RESISTANCE TO ANTI-VEGF AND ANTI-PROTEASE THERAPIES

Project Information

ENDOCAM

Grant agreement ID: 748731

DOI

10.3030/748731

Project closed

EC signature date 3 March 2017

Start date 1 December 2017

End date 1 September 2021

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 244 269,00

EU contribution

€ 244 269,00

Coordinated by

UNIVERSITA DEGLI STUDI DI FIRENZE
Italy

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis

Author(s): Anastasia Chillà, Francesca Margheri, Alessio Biagioni, Mario Del Rosso, Gabriella Fibbi, Anna Laurenzana
Published in: Journal of Experimental & Clinical Cancer Research, Issue 37/1, 2018, ISSN 1756-9966
Publisher: PublisherBioMed Central
DOI: 10.1186/s13046-018-0742-2